BioRay Pharmaceutical

A commercial-stage biopharmaceutical company with a full suite of end-to-end capabilities in China. .

Launch date

2019

Employees

Market cap

Enterprise valuation

€1.7b (Public information from Jan 2023)

Taizhou Jiangsu (HQ)

http://bioraypharm.com

https://www.linkedin.com/company/bioraypharm/

View job openings

Date	Investors	Amount	Round
Jan 2019	Zhejiang Hisun Pharmaceutical	N/A	Corporate spinout
Sep 2019	N/A	N/A	Growth Equity VC
Jan 2023*	N/A	$218m Valuation: $1.9b	Growth Equity VC
Total Funding		€198m

Nascent Biotech